Showing results (1611-1620 of 2,650) with videos related to

Sort By:
Pageof 265
Drug and Alcohol Dependence|November 20, 2016
Effects of the benzodiazepine GABA<sub>A</sub> α1-preferring antagonist 3-isopropoxy-β-carboline hydrochloride (3-ISOPBC) on alcohol seeking and self-administration in baboonsAugust F Holtyn, V V N Phani Babu Tiruveedhula, Michael Rajesh Stephen, et al.
Journal of Medicinal Chemistry|May 1, 1984
Biomimetic approach to potential benzodiazepine receptor agonists and antagonistsF Guzman, M Cain, P Larscheid, et al.
International Journal of Radiation Biology|March 11, 2021
In vivo noninvasive preclinical tumor hypoxia imaging methods: a reviewRebecca A D'Alonzo, Suki Gill, Pejman Rowshanfarzad, et al.
The Journal of Trauma and Acute Care Surgery|August 1, 2012
Is the sympathetic system involved in shock-induced gut and lung injury?Gregg M Baranski, Ziad C Sifri, Kristen M Cook, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2004
Vancomycin-induced deletion of the methicillin resistance gene mecA in Staphylococcus aureusRajan P Adhikari, Georgina C Scales, Kere Kobayashi, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma modelRebecca A D'Alonzo, Synat Keam, Suki Gill, et al.
The Journal of Antimicrobial Chemotherapy|March 11, 2015
Bactericidal mode of action of bedaquilineKiel Hards, Jennifer R Robson, Michael Berney, et al.
The International Journal of Neuropsychopharmacology|March 7, 2009
The differential role of alpha1- and alpha5-containing GABA(A) receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in ratsMiroslav M Savić, Marija M Milinković, Sundari Rallapalli, et al.
Chemistry, an Asian Journal|January 26, 2019
Synthesis and Investigation of Phthalazinones as Antitubercular AgentsKristiana T Santoso, Chen-Yi Cheung, Kiel Hards, et al.
The Oncologist|November 24, 2020
Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor TherapyMadeline M Cook, Luai Al Rabadi, Andy J Kaempf, et al.
Pageof 265